Bristol-Myers Squibb Company
BMY
$66.58
-$0.37-0.55%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.28B | 7.28B | 7.05B | 6.04B | 5.05B |
| Total Depreciation and Amortization | 3.30B | 3.68B | 4.08B | 4.90B | 6.50B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.26B | 3.77B | 3.48B | 3.21B | 3.23B |
| Change in Net Operating Assets | -2.06B | -1.42B | -455.00M | 2.48B | 1.13B |
| Cash from Operations | 12.78B | 13.31B | 14.16B | 16.62B | 15.90B |
| Capital Expenditure | -1.34B | -1.40B | -1.31B | -1.32B | -1.32B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3.74B | -3.93B | -3.94B | -2.28B | -758.00M |
| Divestitures | 1.08B | 1.14B | 1.07B | 1.13B | 1.10B |
| Other Investing Activities | -905.00M | 425.00M | 52.00M | -392.00M | -407.00M |
| Cash from Investing | -4.91B | -3.76B | -4.13B | -2.87B | -1.39B |
| Total Debt Issued | 5.53B | 5.72B | 5.77B | 26.00M | 116.00M |
| Total Debt Repaid | -12.02B | -11.44B | -10.94B | -872.00M | -3.39B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.10B | -5.07B | -5.05B | -5.00B | -4.95B |
| Other Financing Activities | -127.00M | -123.00M | -128.00M | -114.00M | -95.00M |
| Cash from Financing | -11.71B | -10.92B | -10.35B | -5.96B | -8.32B |
| Foreign Exchange rate Adjustments | -57.00M | 81.00M | 195.00M | 43.00M | 124.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.89B | -1.29B | -129.00M | 7.83B | 6.32B |